Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 1,941 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Type 2 Diabetes Mellitus
Interventions: CASM; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 25 Years to 75 Years
Enrollment: 463 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Obesity, Sleep
Interventions: Optimize Sleep (OS), Optimize Sleep-Plus (OS-Plus); Behavioral
Lead sponsor: Temple University; Other
Eligibility: 6 Years to 11 Years
Enrollment: 149 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: ACL Tear
Interventions: Mental Skills Coaching; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 25 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: GLP - 1, Diabetes, Obesity and Obesity-related Medical Conditions, Cardiovascular Diseases
Interventions: Health Coach/Fitbit; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years to 100 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Chronic Kidney Diseases
Interventions: Physical Activity Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Glaucoma
Interventions: Behavioral Activation, Supportive Therapy; Behavioral
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania

Conditions: Gun Shot Wound
Interventions: Hospital-Linked Violence Intervention Program, Mobile Community Event Support, Unrestricted Cash Assistance; Behavioral
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Pediatrics, Medically Complex, Children With Medical Complexity (CMC), Nursing
Interventions: CHAMP App; Device
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 0 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Metastatic Melanoma
Interventions: Nivolumab, Pembrolizumab, Dabrafenib+Trametinib, Ipilimumab+Nivolumab, Vemurafenib+Cobimetinib, Encorafenib+Binimetinib; Drug · Combination Product
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 1,975 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Major Depressive Disorder, Bipolar Disorder
Interventions: Mindfulness-based cognitive therapy; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older · Female only
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Los Angeles, California • Boulder, Colorado

Conditions: Oral Lichen Planus, Oral Lichenoid Reaction
Interventions: dexamethasone oral rinse; Drug
Lead sponsor: Tufts University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognitive Change
Interventions: Visual and / or Auditory Cognitive Tasks (1), Visual and / or Auditory Cognitive Tasks (2); Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Riverside, California • Boston, Massachusetts • Madison, Wisconsin

Conditions: HIV Infections
Interventions: Standard Text-Based Prevention Web Page, The Morning After, Talking About HIV, Both Videos; Behavioral
Lead sponsor: Public Health Solutions; Other
Eligibility: 18 Years and older · Male only
Enrollment: 3,097 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Concussion, Brain, Sleep Disorder
Interventions: Brief Sleep Intervention; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 13 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Peyronie Disease, Erectile Dysfunction
Interventions: Collagenase Clostridium Histolyticum, Storz Duolith LiSWT; Drug · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cancer
Interventions: JTX-8064, pimivalimab; Drug
Lead sponsor: Jounce Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 45
States / cities: Birmingham, Alabama • Gilbert, Arizona • Tucson, Arizona + 37 more

Conditions: Suicide
Interventions: Project Life Force Group Treatment; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Type1diabetes, Cardiovascular Risk Factor
Interventions: Heart healthy intervention; Behavioral
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 14 Years to 19 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Spinal Cord Injury
Interventions: Indego Exoskeleton; Device
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Tampa, Florida • Rochester, Minnesota • Nashville, Tennessee

Conditions: Depression, Psychological Stress, Affect
Interventions: Positive Affect Skills Training; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sexual Violence, Bystander Intervention
Interventions: Safe Bars active bystander training; Behavioral
Lead sponsor: RTI International; Other
Eligibility: 18 Years and older
Enrollment: 3,180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Little Rock, Arkansas • Gainesville, Florida • Durham, North Carolina

Conditions: Foetal Exposure During Pregnancy
Interventions: Electronic SBI; Behavioral
Lead sponsor: Public Health Institute, California; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Oakland, California • Santa Rosa, California

Conditions: Inactivity, Physical
Interventions: Behavior Change Technique Package; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Breast Cancer
Interventions: Pembrolizumab (K), Placebo (P), Paclitaxel (X), Doxorubicin (A), Epirubicin (E), Cyclophosphamide (C), Endocrine therapy, Radiation therapy, Surgery; Biological · Drug · Radiation + 1 more
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 1,240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2031
U.S. locations: 45
States / cities: Daphne, Alabama • Goodyear, Arizona • Tucson, Arizona + 39 more

Search by objective public record fields.

Linking Self-Management and Primary Care for Diabetes 2

Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal

Readiness Outcomes Affecting Return to Sport 2.0: An Intervention Feasibility & Pilot Study

FIT-COACH: Fitbit Intervention With Coordinated Health Coaching and PCP Support

The Efficacy of Physical Activity on Improving Health Outcomes for Renal Transplant Patients

Confronting Unequal Eye Care in Pennsylvania

Mississippi Violence Injury Prevention (VIP) Program

Parental Adherence of a Mobile Application

Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden

Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders

Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus

Effectiveness of Cognitive Training in Older and Younger Adults

Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men

Addressing Sleep in Adolescents Post-Concussion ("ASAP Study")

Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors

Suicide Safety Planning Group Treatment: "Project Life Force"

Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes

Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2)

Online Positive Emotion Skills Intervention for Symptoms of Depression

Safer Drinking Spaces Study

Computerized Tool for Preventing Prenatal Drinking

BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRD

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)